Devices and methods for the treatment of cancer
AssigneeOncosil Medical Ltd.
InventorsRoger ASTON, Leigh T. CANHAM
Life of this patent
Estimating the term…
Abstract
The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer.
Claims16
An internal therapeutic product comprising:
- (i) an anti-cancer component comprising at least one radionucleotide and/or at least one cytotoxic drug;
- and
- (ii) a silicon component selected from one or more of:
- resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon.
A method of treating a cancer, the method comprising the step of introducing an internal therapeutic product into a patient, the internal therapeutic product comprising:
- (i) a silicon component selected from one or more of:
- resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, bulk crystalline silicon;
- and
- (ii) an anti-cancer component comprises at least one radionucleotide and/or at least one cytotoxic drug.
Dependencies are inferred from the claim text.